All ProductsDisplaying Products Alphabetically by Name (C)
Cat. No. | Product Name / Activity |
---|---|
3581 | C 021 dihydrochloride |
Potent CCR4 antagonist | |
8007 | C 101248 |
Selective and potent inhibitor of both mouse and human THIK-1 | |
7040 | C 176 |
mSTING antagonist | |
2489 | C 75 |
Potent fatty acid synthase inhibitor; proapoptotic | |
5821 | C-DIM 12 |
Nurr1 activator; inhibits NF-κB-dependent gene expression | |
7273 | C-Laurdan |
Two-photon polarity-sensitive lipid membrane probe. Used for: cell membrane imaging. Application: One and Two-photon microscopy for membrane Polarity | |
3520 | C-type natriuretic peptide (1-22) (human, rat, swine) |
Endogenous peptide agonist at NPR2 | |
5382 | C16 |
PKR inhibitor | |
7715 | C25-140 |
TRAF6-Ubc13 interaction inhibitor | |
7692 | C26-A6 |
Disrupts MTDH and SND1 interaction, enhances immune surveillance | |
7546 | C28 |
Potent LMTK3 inhibitor | |
5373 | C34 |
TLR4 inhibitor | |
4863 | CA 074 |
Selective cathepsin B inhibitor | |
8105 | CAF 382 |
Potent and selective CDKL5 inhibitor | |
7457 | CAM 833 |
Selective orthosteric inhibitor of the BRCA2-RAD51 interaction | |
3337 | CART (55-102) (rat) |
Neuromodulatory neuropeptide fragment; satiety factor | |
5050 | CASIN |
Cdc42 inhibitor | |
5903 | CATPB |
FFA2 (GPR43) inverse agonist | |
7379 | CB 5083 |
Potent p97 ATPase inhibitor | |
2663 | CB 65 |
High affinity, selective CB2 agonist | |
7591 | CB 839 |
Potent glutaminase GLS1 inhibitor | |
6724 | CBA |
Selective TRPM4 blocker | |
6319 | CBM 301940 |
Potent malonyl-CoA decarboxylase inhibitor; orally bioavailable | |
7890 | CBMR 0083 |
Potent allosteric FFA1 (GPR40) and 4 (GPR120) agonist | |
7018 | CBR-470-1 |
PGK1 inhibitor; activates Nrf2 | |
6258 | CC 401 dihydrochloride |
High affinity JNK inhibitor; also inhibits HCMV replication | |
5236 | CC4 |
High affinity and subtype-selective α6β2 and α4β2 nAChR partial agonist | |
0452 | CCCP |
Oxidative phosphorylation uncoupler | |
0333 | L-CCG-l |
Potent group II mGlu agonist | |
1166 | CCK Octapeptide, sulfated |
C-terminal octapeptide of CCK | |
3837 | CCMI |
Positive allosteric modulator of α7 nAChRs | |
2435 | CCT 018159 |
Hsp90 inhibitor | |
4968 | CCT 241533 dihydrochloride |
Potent Chk2 inhibitor | |
4546 | rac-CCT 250863 |
Potent Nek2 inhibitor | |
7799 | CCT 369260 |
Molecular glue; induces degradation of BCL6 | |
2554 | CD 1530 |
Potent and selective RARγ agonist | |
3824 | CD 2314 |
Selective RARβ agonist | |
3800 | CD 2665 |
Selective RARβ/γ antagonist | |
3302 | CD 3254 |
Potent and selective RXRα agonist | |
1549 | CD 437 |
RARγ-selective agonist | |
8830 | CD22L-N3 (BPC-Sia-LacNAc-N3) New |
CD22L ligand with azide group for onward chemistry | |
6391 | CD38 inhibitor 78c |
Potent CD38 inhibitor; active in vivo | |
4737 | CDDO Im |
Nrf2 signaling activator | |
7372 | CDK8/19i |
Potent and selective CDK8 and CDK19 inhibitor; maintains pluripotency of mouse PSCs in culture | |
5869 | CDN 1163 |
SERCA2 allosteric activator | |
3235 | CDPPB |
Positive allosteric modulator of mGlu5 receptors | |
4793 | CE3F4 |
Noncompetitive Epac1 inhibitor | |
5969 | (R)-CE3F4 |
Epac inhibitor; R-enantiomer of CE3F4 (Cat. No. 4793) | |
7952 | CELT-133 |
Selective hα1A adrenergic receptor fluorescent antagonist | |
7953 | CELT-211 |
Fluorescent serotonin 5HT2B receptor ligand for HTS | |
7954 | CELT-327 |
Potent and selective hA2B/A3 adenosine receptor fluorescent antagonist | |
7955 | CELT-426 |
Potent and partially selective hD2 dopamine receptor fluorescent antagonist | |
8108 | CEP |
Chemoproteomic reagent, clickable electrophilic purine for RNA binding profiling in live cells | |
4924 | CEP 1347 |
Inhibitor of JNK signaling | |
7991 | CEPT Cocktail Kit |
Cell culture supplement for improving stem cell survival | |
3430 | CFTRinh 172 |
Voltage-independent, selective CFTR chloride channel blocker | |
7425 | CG 428 |
Potent tropomyosin receptor kinase (TRK) Degrader | |
7426 | CG 428-Neg |
Negative control for CG 428 (Cat. No. 7425) | |
7427 | CG 858 |
Selective BRAF-V600E protein Degrader (uSMITE™) | |
7428 | CG 858-Neg |
Negative control for CG 858 (Cat. No. 7427) | |
6965 | CGI 1746 |
Potent, reversible BTK inhibitor | |
1134 | CGP 12177 hydrochloride |
β3 partial agonist. β1/β2 antagonist | |
1024 | CGP 20712 dihydrochloride |
Highly potent and selective β1 antagonist | |
2966 | CGP 3466B maleate |
GAPDH inhibitor; neuroprotective | |
1245 | CGP 35348 |
Selective GABAB antagonist; brain penetrant | |
3219 | CGP 36216 hydrochloride |
GABAB antagonist; displays activity at presynaptic receptors | |
1114 | CGP 37157 |
Antagonist of mitochondrial Na+/Ca2+ exchange | |
1469 | CGP 37849 |
Potent and selective NMDA antagonist | |
2569 | CGP 42112 |
Selective, high affinity AT2 ligand | |
1247 | CGP 46381 |
Selective GABAB antagonist; brain penetrant | |
1246 | CGP 52432 |
Potent and selective GABAB antagonist | |
2442 | CGP 53353 |
Selective inhibitor of PKCβII | |
1088 | CGP 54626 hydrochloride |
Potent and selective GABAB antagonist | |
1248 | CGP 55845 hydrochloride |
Potent and selective GABAB antagonist | |
2731 | CGP 57380 |
Selective inhibitor of Mnk1 | |
5471 | CGP 60474 |
Potent cdk inhibitor | |
2199 | CGP 71683 hydrochloride |
Highly selective and potent non-peptide NPY Y5 receptor antagonist | |
5472 | CGP 74514 dihydrochloride |
Potent CDK1 inhibitor | |
1493 | CGP 78608 hydrochloride |
Potent and selective NMDA antagonist; acts at glycine site | |
1513 | CGP 7930 |
Positive allosteric modulator of GABAB receptors | |
3012 | α-CGRP (human) |
CGRP agonist | |
1161 | CGRP (rat) |
Potent vasodilator | |
1181 | CGRP 8-37 (human) |
CGRP antagonist | |
1169 | CGRP 8-37 (rat) |
CGRP antagonist | |
0638 | CGS 12066B dimaleate |
5-HT1B agonist | |
1699 | CGS 15943 |
Potent adenosine receptor antagonist | |
1241 | CGS 19755 |
Potent competitive NMDA antagonist | |
1063 | CGS 21680 hydrochloride |
A2A agonist | |
2512 | CGS 35066 |
Endothelin-converting enzyme (ECE) inhibitor | |
2255 | CGS 9343B |
Calmodulin antagonist | |
3858 | CH 223191 |
Potent aryl hydrocarbon receptor (AhR) antagonist | |
5029 | CHC |
MCT inhibitor; decreases glycoloysis | |
6725 | CHDI 00390576 |
Potent and selective class IIa HDAC inhibitor; brain penetrant | |
7879 | CHDI 00484077 |
Potent and selective HDAC class IIa inhibitor | |
8063 | CHDI 113 |
Potent HTT pre-RNA splicing modulator | |
8044 | CHIPOpt New |
CHIP/STUB1 E3 ligase inhibitor | |
6695 | CHIR 98014 |
Highly potent and selective GSK-3 inhibitor | |
TB4423-GMP | CHIR 99021 |
CHIR 99021 synthesized to cGMP guidelines | |
4953 | CHIR 99021 trihydrochloride |
Hydrochloride salt of CHIR 99021 (Cat. No. 4423); selective GSK-3 inhibitor | |
8170 | CHIR 99021 in solution New |
Sterile-filtered 10 mM solution of CHIR 99021 pre-dissolved in DMSO | |
1049 | CHPG |
mGlu5 selective agonist | |
3695 | CHPG Sodium salt |
Selective mGlu5 agonist; sodium salt of CHPG (Cat. No. 1049) | |
3595 | CHR 2797 |
Aminopeptidase inhibitor | |
5326 | CHR 6494 trifluoroacetate |
Potent and selective haspin inhibitor | |
6753 | CHS 828 |
NAMPT inhibitor; active in vivo and cytotoxic | |
1296 | CI 966 hydrochloride |
Selective inhibitor of GAT-1 | |
2227 | CI 976 |
Selective ACAT inhibitor | |
2607 | CI 988 |
Potent and selective CCK2 antagonist | |
7494 | CIA 1 |
COUP-TFII inhibitor | |
6544 | CID 1375606 |
GPR27 agonist | |
4959 | CID 16020046 |
Selective GPR55 antagonist | |
4293 | CID 2745687 |
GPR35 antagonist | |
3327 | CID 755673 |
Selective protein kinase D inhibitor | |
5521 | CIM 0216 |
Selective TRPM3 agonist | |
7812 | CIMBA hydrochloride |
Potent and selective G protein-coupled estrogen receptor (GPER) antagonist | |
4105 | CIQ |
Potentiator of NMDA receptors containing GluN2C/GluN2D | |
3683 | CITCO |
Selective CAR agonist | |
7811 | CITFA |
Potent G protein-coupled estrogen receptor (GPER) agonist | |
3950 | CK 666 |
Arp2/3 inhibitor; inhibits actin polymerization | |
5329 | CKI 7 dihydrochloride |
CK1 inhibitor | |
1499 | CL 316243 disodium salt |
Highly selective β3 agonist | |
2632 | CL 82198 hydrochloride |
Selective inhibitor of MMP-13 | |
5582 | TAT-cyclo-CLLFVY |
Selective HIF-1 dimerization inhibitor | |
5242 | CLP 257 |
Selective KCC2 activator | |
6758 | CLP 290 |
K+/Cl- cotransporter 2 (KCC2) activator; orally bioavailable prodrug of CLP 257 (Cat. No.5242) | |
6416 | CM 11 |
Homo-PROTAC® for self-degradation of pVHL30 | |
6677 | CMA |
Murine-selective STING agonist | |
2186 | CMPD-1 |
Selective inhibitor of p38α-mediated MK2a phosphorylation; also tubulin polymerization inhibitor | |
5642 | CMPD101 |
Potent and selective GRK2/3 inhibitor | |
5963 | CMPI hydrochloride |
Potent positive allosteric modulator of α4β2 nAChRs; also inhibitor of (α4)2(β2)3, muscle-type and Torpedo nAChRs | |
4642 | 4-CMTB |
FFA2 agonist; also exhibits positive allosteric modulatory activity | |
0190 | CNQX |
Potent and selective non-NMDA iGluR antagonist | |
1045 | CNQX disodium salt |
Potent non-NMDA iGluR antagonist; more water soluble form of CNQX (Cat. No. 0190) | |
6354 | CNV Dopamine |
Caged dopamine; photolysed by UV light | |
3405 | COG 133 |
ApoE peptide fragment | |
5320 | CORM 3 |
Water-soluble carbon monoxide-releasing molecule | |
4193 | CP 100356 hydrochloride |
P-gp inhibitor | |
3649 | CP 122721 hydrochloride |
High affinity NK1 antagonist | |
2779 | CP 154526 |
Selective, non-peptide CRF1 antagonist | |
3542 | CP 316819 |
Selective glycogen phosphorylase inhibitor | |
3212 | CP 376395 hydrochloride |
Potent and selective CRF1 antagonist; binds at an allosteric site | |
6558 | CP 43 |
Potent TAOK inhibitor | |
2932 | CP 465022 hydrochloride |
Selective and non-competitive AMPA antagonist | |
5993 | CP 673451 |
Potent and selective PDGFR inhibitor | |
4556 | CP 690550 citrate |
Potent JAK inhibitor | |
4190 | CP 775146 |
Selective, high affinity PPARα agonist | |
3041 | CP 809101 hydrochloride |
Potent and selective 5-HT2C agonist | |
1032 | CP 93129 dihydrochloride |
5-HT1B agonist | |
1317 | CP 94253 hydrochloride |
Potent and selective 5-HT1B agonist | |
4236 | CP 945598 hydrochloride |
CB1 antagonist | |
2893 | CP 96345 |
Potent and selective NK1 antagonist | |
3417 | CP 99994 dihydrochloride |
High affinity NK1 antagonist | |
1028 | CPCCOEt |
Selective non-competitive mGlu1 antagonist | |
5331 | CPI 203 |
BET bromodomain inhibitor; arrests cell cycle at G1 phase | |
0247 | (R)-CPP |
Potent NMDA antagonist; more active enantiomer of (RS)-CPP | |
0173 | (RS)-CPP |
Potent NMDA antagonist | |
0972 | CPPG |
Potent group III mGlu antagonist | |
1265 | D-CPP-ene |
Potent competitive NMDA antagonist | |
7800 | CPS2 |
Potent and selective CDK2 Degrader (PROTAC®) | |
4400 | (±)-CPSI 1306 |
Reported macrophage migration inhibitory factor (MIF) inhibitor | |
2688 | CPT 11 |
DNA topoisomerase I inhibitor; antitumor | |
1645 | 8-CPT-2Me-cAMP, sodium salt |
Selective Epac activator | |
4568 | CPYPP |
DOCK2-Rac1 interaction inhibitor | |
3605 | (R)-CR8 |
Cdk inhibitor; potently inhibits cdk1 and cdk2; also inhibits CK1; acts as molecular glue | |
4803 | CRANAD 2 |
Near-infrared probe that detects Aβ40 aggregates. Used for: amyloid-β detection in vitro and in vivo. Application: fluorescence microscopy, epifluorescence microscopy | |
7219 | CRBN PROTAC® 14a |
Cereblon Degrader (PROTAC®) | |
6948 | CRBN-6-5-5-VHL |
Potent and selective cereblon Degrader (PROTAC®); cell-permeable | |
1151 | CRF (human, rat) |
Stimulates ACTH release | |
5479 | CRID3 sodium salt |
Potent NLRP3 inflammasome inhibitor; inhibits IL-1β production | |
4975 | CRT 0066101 |
Potent protein kinase D (PKD) inhibitor | |
5922 | CRT 0066854 hydrochloride |
PKCι and PKCζ inhibitor | |
6273 | CRT 0105950 |
Potent LIMK1/2 inhibitor | |
4543 | CS 2100 |
Selective S1P1 agonist | |
7982 | CS 640 |
Potent CaM kinase I inhibitor | |
7089 | CSN5i-3 |
Potent and selective CSN5 (COP9 signalosome) inhibitor | |
7532 | CSN5i-3-NEG |
Negative control for CSN5i-3 (Cat. No. 7089) | |
8066 | CST 530, Phenol |
Functionalized IAP ligand for PROTACs® | |
8021 | CST 626 |
Potent pan IAP Degrader (PROTAC®) | |
7745 | CST 905 |
Potent and selective BRAFV600E Degrader (PROTAC®) | |
7801 | CST 967 |
Potent and selective USP7 Degrader (PROTAC®) | |
4726 | CTA 056 |
ITK inhibitor | |
1560 | CTAP |
Potent and selective μ antagonist | |
5130 | CTCE 9908 |
CXCR4 antagonist; antitumor | |
1578 | CTOP |
Potent and selective μ antagonist | |
7794 | CTPI 2 |
Selective mitochondrial citrate transporter (SLC25A1) inhibitor | |
4884 | CU CPT 22 |
Selective TLR1/2 inhibitor | |
4883 | CU CPT 4a |
Selective TLR3 inhibitor | |
6479 | CU CPT 9a |
Highly potent TLR8 inhibitor | |
7820 | CU-76 |
Selective inhibitor of cyclic GMP-AMP synthase (cGAS) | |
5414 | CU-T12-9 |
Potent TLR1/2 agonist | |
5164 | CVT 10216 |
Potent and selective ALDH2 inhibitor | |
6174 | CVT 313 |
Cdk2 and cdk5 inhibitor | |
5495 | CW 008 |
PKA signaling activator; promotes osteogenesis from hMSCs | |
6144 | CX08005 |
Competitive PTP1B inhibitor | |
2980 | CX 546 |
AMPA potentiator | |
5149 | CX 614 |
Positive allosteric modulator of AMPA receptors | |
6436 | CY 09 |
NLRP3 inhibitor; active in vivo | |
1249 | CY 208-243 |
Selective D1-like agonist | |
4677 | CYM 50260 |
Potent and selective S1P4 agonist | |
4678 | CYM 50308 |
Potent and selective S1P4 agonist | |
4679 | CYM 50358 hydrochloride |
Potent and selective S1P4 antagonist | |
4948 | CYM 50769 |
Novel non-peptide NPBWR1 antagonist | |
3601 | CYM 5442 hydrochloride |
Selective S1P1 receptor agonist | |
5418 | CYM 5520 |
Selective S1P2 allosteric agonist | |
4897 | CYM 5541 |
Selective S1P3 receptor allosteric agonist | |
4606 | CYM 9484 |
Potent NPY Y2 receptor antagonist | |
1843 | CYN 154806 |
Selective sst2 antagonist | |
6071 | CZC 25146 |
Potent LRRK2 inhibitor | |
4877 | CaCCinh-A01 |
Calcium-activated chloride channel (CaCC) inhibitor | |
2664 | Cabergoline |
D2-like agonist (D2>D3>D4) | |
6264 | Caerulein |
CCK agonist | |
2743 | Caffeic acid phenethyl ester |
Specific inhibitor of NF-κB activation | |
2793 | Caffeine |
A1 and A2B antagonist. CNS stimulant | |
7181 | Caffeine Orange |
Selective, BODIPY-based fluorescent caffeine chemosensor | |
5119 | Calcein AM |
Cell permeable non-fluorescent compound; green-fluorescent in living cells once hydrolyzed. Used for: cell tracing and cell viability monitoring. Application: fluorescent microscopy and flow cytometry | |
2700 | Calcipotriol |
Vitamin D3 analog | |
6031 | Calcitonin (human) |
Endogenous calcitonin agonist; inhibits bone resorption | |
1159 | Calcitonin (salmon) |
Affects bone formation and resorption | |
2551 | Calcitriol |
Vitamin D receptor (VDR) agonist | |
4387 | Calhex 231 hydrochloride |
Negative allosteric modulator of calcium-sensing receptor (CaSR) | |
2561 | Calmidazolium chloride |
Calmodulin antagonist | |
1626 | Calphostin C |
Potent, selective and photo-dependent PKC inhibitor | |
1336 | Calyculin A |
Protein phosphatase 1 and 2A inhibitor | |
7137 | Cambinol |
nSMase2 inhibitor | |
3193 | Camostat mesylate |
Orally active protease inhibitor; inhibits entry of SARS-Cov-2 into lung cells | |
1100 | Camptothecin |
DNA topoisomerase inhibitor | |
4791 | Candesartan |
AT1 antagonist | |
5916 | Canertinib dihydrochloride |
Potent EGFR kinase inhibitor | |
1570 | (-)-Cannabidiol |
Natural cannabinoid; GPR55 antagonist, weak CB1 antagonist, CB2 inverse agonist and AMT inhibitor | |
3021 | Cannabigerol |
Cannabinoid receptor partial agonist | |
0462 | (E)-Capsaicin |
TRPV agonist | |
0464 | Capsazepine |
TRPV antagonist; also activator of ENaCδ | |
6781 | Capzimin dimer |
Selective proteasome inhibitor | |
4098 | Carbamazepine |
Inhibitor of neuronal NaV channels; anticonvulsant | |
2810 | Carbamoylcholine chloride |
Non-selective cholinergic agonist | |
3096 | Carbenoxolone disodium |
Gap junction blocker. Also inhibitor of 11 β-hydroxysteroid dehydrogenase | |
4852 | Carbetocin |
Oxytocin analog | |
0455 | (S)-(-)-Carbidopa |
Aromatic L-amino acid decarboxylase inhibitor | |
2626 | Carboplatin |
DNA cross-linking antitumor agent | |
0458 | 5-Carboxamidotryptamine maleate |
5-HT1 agonist; also has high affinity for 5-ht5a and 5-HT7 | |
0323 | (S)-4-Carboxyphenylglycine |
Competitive group I mGlu antagonist; also weak group II agonist | |
2509 | Cardamonin |
Inhibitor of NF-κB activation; anti-inflammatory | |
7188 | Carfilzomib |
Potent irreversible proteasome inhibitor; active in vivo | |
5358 | Cariporide |
Selective NHE1 inhibitor; cardioprotective and antitumor | |
2685 | Carvedilol |
Potent and non-selective β antagonist; also potent α1 antagonist | |
7139 | CeMMEC1 |
TAF1 inhibitor | |
6955 | Ceapin A7 |
Selective inhibitor of ATF6α; sensitizes cells to ER stress | |
7454 | Cediranib |
Potent inhibitor of VEGFR, PDGFR and FGFR | |
5867 | Ceefourin 1 |
Selective MRP4 inhibitor | |
3203 | Celastrol |
Inhibits TNF-α-induced NF-κB activation | |
3786 | Celecoxib |
Selective cyclooxygenase-2 (COX-2) inhibitor | |
5476 | Cell Activation Cocktail 500X |
Cell activation cocktail | |
7368 | Cell Counting Kit-8 |
Cell viability and proliferation assay test solution | |
5687 | Centrinone |
High affinity and selective PLK4 inhibitor | |
5690 | Centrinone B |
High affinity and selective PLK4 inhibitor | |
0744 | Ceramide |
Ser/Thr protein phosphatase activator | |
4448 | Ceranib 1 |
Ceramidase inhibitor; antiproliferative | |
4500 | Cercosporamide |
Potent Mnk2 inhibitor | |
4492 | Cerestat |
Potent and noncompetitive NMDA antagonist | |
6905 | Ceritinib |
Highly potent ALK inhibitor; also potently inhibits IR, IGF1R, STK22D and FLT3 | |
3536 | Cetrorelix Acetate |
Potent GnRH receptor antagonist | |
3689 | Cevimeline hydrochloride |
Selective M1 agonist | |
2020 | Ch 55 |
Potent RAR agonist | |
4504 | Chaetocin |
SUV39H1 inhibitor | |
1330 | Chelerythrine chloride |
Cell-permeable protein kinase C inhibitor | |
7769 | Chem-CLIP control probe |
Control probe for Chem-CLIP experiments | |
7116 | Chemerin-9, Human |
Potent CMKLR1 agonist; c-terminal peptide of full length human chemerin | |
7117 | Chemerin-9, Mouse |
Potent CMKLR1 agonist; c-terminal peptide of full length mouse chemerin | |
0456 | Chlormezanone |
Positive allosteric modulator of benzodiazepine site | |
1705 | 2-Chloro-N6-cyclopentyladenosine |
Potent and selective A1 agonist | |
3136 | 2-Chloroadenosine |
Adenosine receptor agonist | |
3697 | 7-Chlorokynurenic acid sodium salt |
Potent competitive inhibitor of L-glutamate uptake. Sodium salt of 7-Chlorokynurenic acid (Cat. No. 0237) | |
0237 | 7-Chlorokynurenic acid |
Potent competitive inhibitor of L-glutamate uptake | |
0938 | p-Chlorophenylalanine |
Tryptophan hydroxylase inhibitor | |
0440 | m-Chlorophenylbiguanide hydrochloride |
Potent and selective 5-HT3 agonist | |
0442 | 4-Chlorophenylguanidine hydrochloride |
Urokinase inhibitor | |
4109 | Chloroquine diphosphate |
Antimalarial; inhibits apoptosis and autophagy | |
7945 | Cholesterol |
Component of lipid nanoparticles (LNPs); modulator of lipid bilayer fluidity | |
7163 | Chroman 1 |
Highly potent and selective ROCK 2 inhibitor; improves cell survival after cryogenesis | |
1412 | Chromanol 293B |
IKs blocker. Also blocks ICFTR | |
1475 | (-)-[3R,4S]-Chromanol 293B |
IKs blocker. Enantiomer of Chromanol 293B (Cat. No. 1412) | |
6357 | Ciclesonide |
Glucocorticoid antiasthmatic prodrug | |
6384 | Ciclopirox |
Pan-histone demethylase inhibitor | |
5870 | Cilengitide |
Potent and selective inhibitor of integrins αvβ3 and αvβ5 | |
4529 | Ciliobrevin A |
Hedgehog (Hh) pathway antagonist, inhibits ciliogenesis; also inhibits dynein | |
2629 | Cilnidipine |
Dual CaV1.x and CaV2.x blocker | |
0915 | Cilostamide |
PDE3 inhibitor | |
1692 | Cilostazol |
PDE3A inhibitor. Also adenosine uptake inhibitor | |
0902 | Cimetidine |
H2 antagonist, I1 agonist | |
6170 | Cinacalcet hydrochloride |
Allosteric Calcium-sensing receptor (CaSR) agonist; also CYP2D2 inhibitor and Ca2+ channel blocker; orally bioavailable | |
0460 | Cinanserin hydrochloride |
Selective 5-HT2 antagonist; also 3C-like proteinase inhibitor | |
0888 | Cirazoline hydrochloride |
Selective α1 agonist | |
1695 | Cisapride |
5-HT4 agonist; stimulates intestinal ACh release | |
2251 | Cisplatin |
Potent pro-apoptotic anticancer agent; activates caspase-3 | |
1427 | Citalopram hydrobromide |
Highly potent and selective 5-HT uptake inhibitor | |
5763 | (R)-Citalopram oxalate |
Enantiomer of escitalopram oxalate (Cat. No. 1427) | |
3812 | Cl-4AS-1 |
Steroidal androgen receptor agonist | |
6321 | 10-Cl-BBQ |
Potent aryl hydrocarbon receptor (AhR) agonist; orally bioavailable | |
1104 | 2-Cl-IB-MECA |
Highly selective A3 agonist | |
5292 | Cladribine |
Deoxyadenosine analog; pro-apoptotic | |
1453 | Clemastine fumarate |
H1 antagonist | |
6798 | Click N-Acetylmuramic acid - alkyne |
Bacterial peptidoglycan derivative; suitable for 'click'-conjugation to fluorescent dyes | |
7506 | Click N-Acetylmuramic acid - azide |
Bacterial peptidoglycan derivative; suitable for 'click'-conjugation to fluorescent dyes | |
0752 | Clobenpropit dihydrobromide |
Highly potent H3 antagonist and H4 partial agonist | |
0898 | Clocinnamox mesylate |
Irreversible μ antagonist | |
2600 | Clofarabine |
Deoxycytidine kinase (dCK) substrate | |
0690 | Clonidine hydrochloride |
α2 agonist. Also I1 ligand | |
1820 | (+)-Clopidogrel hydrogen sulfate |
Selective P2Y12 antagonist | |
2490 | (±)-Clopidogrel hydrochloride |
Selective P2Y12 antagonist | |
4096 | Clotrimazole |
Cytochrome P450 inhibitor; antifungal | |
0444 | Clozapine |
Dopamine antagonist with some D4 selectivity; also 5-HT2A/2C antagonist | |
4936 | Clozapine N-oxide |
Activator of hM3Dq and hM4Di DREADDs | |
6329 | Clozapine N-oxide dihydrochloride |
Activator of hM3Dq and hM4Di DREADDs; water soluble version of Clozapine N-oxide (Cat. No. 4936) | |
2456 | Co 101244 hydrochloride |
GluN2B-selective NMDA antagonist | |
1364 | Colchicine |
Inhibitor of tubulin | |
3945 | Colivelin |
STAT3 activator; also protects against β-amyloid neurotoxicity | |
6476 | Compound E |
γ-secretase inhibitor; induces neuronal differentiation | |
2585 | Compstatin |
C3-binding peptide; inhibits complement activation | |
3796 | Compstatin control peptide |
Control peptide for Compstatin (Cat. No. 2585) | |
2656 | Concanamycin A |
H+-ATPase (vacuolar) inhibitor | |
7056 | Conduritol B epoxide |
Irreversible glucocerebrosidase (β-glucosidase) inhibitor; used to generate Gaucher disease models | |
6830 | Conivaptan hydrochloride |
Very high affinity vasopressin V1A and V2 antagonist; orally bioavailable | |
1085 | ω-Conotoxin GVIA |
CaV2.2 blocker | |
8817 | CoraFluor™ 1, Haloalkane New |
Cell impermeable terbium cryptate FRET donor for TR-FRET assay development, with chloroalkane ligand | |
7920 | CoraFluor™ 1, amine reactive |
Terbium cryptate FRET donor for TR-FRET assay development; amine reactive for conjugation | |
8117 | CoraFluor™ 1, thiol reactive New |
Terbium cryptate FRET donor for TR-FRET assay development, cysteine reactive for conjugation | |
8818 | CoraFluor™ 2, Haloalkane New |
Cell permeable terbium cryptate FRET donor for TR-FRET assay development, with chloroalkane ligand | |
7950 | CoraFluor™ 2, amine reactive |
Terbium cryptate FRET donor for TR-FRET assay development; amine reactive for conjugation | |
2294 | Cordycepin |
RNA synthesis inhibitor | |
3685 | Corticosterone |
Endogenous glucocorticoid | |
3374 | Cortistatin 14 |
Endogenous neuropeptide; binds sst1 - sst5, ghrelin receptor and MRGPRX2 | |
7485 | Covidcil-19 |
Binds to SARS-CoV-2 frameshifting element and reduces frameshifting efficiency | |
4368 | Crizotinib |
Potent c-MET/ALK inhibitor | |
6025 | (S)-Crizotinib |
MTH1 inhibitor | |
1571 | Cucurbitacin I |
Selective inhibitor of STAT3/JAK2 signaling | |
7394 | Cy5B-trisulfo, NHS |
Restricted conformation cyanine dye with high quantum yield and long fluorescence lifetime for advanced microscopy applications | |
2953 | CyPPA |
KCa2.2 and KCa2.3 (SK) channel activator | |
6457 | Cyanine 3 Tyramide |
Orange fluorescent reagent widely used for signal amplification in IHC and FISH | |
6458 | Cyanine 5 Tyramide |
Red fluorescent reagent widely used for signal amplification in IHC and FISH | |
5436 | Cyanine 5, SE |
Red fluorescent dye (Reactive group: NHS ester). Application: confocal microscopy, fluorescence microscopy, flow cytometry | |
0993 | Cyanopindolol hemifumarate |
5-HT1A and 5-HT1B antagonist; also β-adrenergic antagonist | |
3180 | α-Cyclodextrin |
Cyclic complexing agent | |
3181 | β-Cyclodextrin |
Cyclic complexing agent | |
0970 | Cycloheximide |
Inhibitor of protein synthesis | |
1623 | Cyclopamine |
Inhibitor of Hedgehog (Hh) signaling | |
6137 | 8-Cyclopentyl-1,3-dimethylxanthine |
High affinity adenosine A1 receptor antagonist | |
1702 | N6-Cyclopentyladenosine |
Potent and selective A1 agonist | |
4091 | Cyclophosphamide |
Alkylating agent; chemotherapeutic | |
1235 | Cyclopiazonic acid |
Inhibitor of SERCA ATPase | |
3493 | Cyclosomatostatin |
Non-selective sst antagonist | |
1101 | Cyclosporin A |
Calcineurin inhibitor | |
6982 | Cyclosporin H |
Enhances lentiviral transduction | |
0713 | Cyclothiazide |
Positive allosteric modulator of AMPA receptors; inhibits AMPA desensitization | |
5062 | Cyclotraxin B |
TrkB receptor antagonist | |
2601 | Cyprodime hydrochloride |
Selective μ antagonist | |
7337 | Cysmethynil |
ICMT inhibitor; arrests cell-cycle at G1 phase | |
4520 | Cytarabine |
Nucleoside analog; inhibits DNA replication | |
1390 | (-)-Cytisine |
Potent and selective neuronal nAChRagonist | |
5474 | Cytochalasin B |
Inhibitor of actin polymerization | |
1233 | Cytochalasin D |
Disrupts actin filament function | |
5459 | Cytosporone B |
High affinity Nur77 agonist |
Tocris Products by Catalog Number
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800